A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemothe...

Por Krivak, Thomas C., Tian, Chunqiao, Rose, G. Scott, Armstrong, Deborah K., Maxwell, G. Larry
Publicado no Gynecol Oncol (2009)

Race Does Not Impact Outcome for Advanced Ovarian Cancer Patients Treated With Cisplatin/Paclitaxel: An Analysis of Gynecologic Oncology Group Trials

Por Farley, John H., Tian, Chunqiao, Rose, G. Scott, Brown, Carol L., Birrer, Michael, Maxwell, G. Larry
Publicado no Cancer (2009)

CHEMOTHERAPY INTENSITY AND TOXICITY AMONG BLACK AND WHITE WOMEN WITH ADVANCED AND RECURRENT ENDOMETRIAL CANCER: A GYNECOLOGIC ONCOLOGY GROUP STUDY

Por Farley, John H., Tian, Chunqiao, Rose, G. Scott, Brown, Carol L., Birrer, Michael, Risinger, John I, Thigpen, J. Tate, Fleming, Gini F., Gallion, Holly H., Maxwell, G. Larry
Publicado em 2010

The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: A gynecologic oncology group study (,,)

Por Hamilton, Chad A., Miller, Austin, Miller, Caela, Krivak, Thomas C., Farley, John H., Chernofsky, Mildred R., Stany, Michael P., Rose, G. Scott, Markman, Maurie, Ozols, Robert F., Armstrong, Deborah K., Maxwell, G. Larry
Publicado em 2011